Results 271 to 280 of about 74,021 (384)
U.S. Emergency Department Visits for Dizziness and Vertigo From 2016 to 2022. [PDF]
Miulli MM, Kim HS.
europepmc +1 more source
EXTH-65. EXPLORING ANTIHISTAMINES TO TREAT GLIOBLASTOMA [PDF]
Poonam Yadav +5 more
openalex +1 more source
A case of propylthiouracil induced antineutrophil cytoplasmic antibody associated vasculopathy
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Nikhil Dwivedi +2 more
wiley +1 more source
ABSTRACT Aim To evaluate the efficacy of professional mechanical plaque removal (PMPR) for treating naturally occurring dental biofilm–induced gingivitis (i) compared to no treatment or oral hygiene instructions (OHI) (FQ1), (ii) when performed through different modalities (FQ2) or (iii) when combined with professionally administered local adjuncts ...
Roberto Farina +5 more
wiley +1 more source
Cost-effectiveness of antihistaminics in adults' patients with allergic rhinitis. [PDF]
Buendía JA, Patino DG.
europepmc +1 more source
Bilastine is a new antihistamine using in the treatment of allergic rhinitis
А. А. Кривопалов +3 more
openalex +1 more source
D-dimer: a biomarker for antihistamine-resistant chronic urticaria.
R. Asero
semanticscholar +1 more source
Bullous Wells’ syndrome successfully treated with omalizumab
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Giulia Ciccarese +7 more
wiley +1 more source
Therapeutic advances in pruritus as a model of personalized medicine
Recent advances in itch biology reveal that chronic pruritus arises from distinct neuroimmune pathways driven by cytokines, JAK, BTK and GPCRs. Targeted biologics and small molecule inhibitors such as dupilumab, nemolizumab, remibrutinib and JAK inhibitors precisely modulate these pathways, leading to a new era of personalized therapeutics in pruritus.
Kelsey Auyeung +2 more
wiley +1 more source

